Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection
Elevated serum levels of transforming growth factor β receptor 2 (TGFBR2) that were significantly higher in those with moderate as compared with those with mild and those without any PCC symptoms may indicate the involvement of TGFBR2 related pathways in the pathogenesis of PCC, in particular in those with cognitive sy...